Literature DB >> 21391160

Menstrual and oral contraceptive use patterns among deployed military women by race and ethnicity.

Patricia A Deuster1, Nicole Powell-Dunford, Mark S Crago, Amanda S Cuda.   

Abstract

Menstrual cycle patterns and concerns and oral contraceptive use in the combat environment were examined in Caucasian, Asian, Hispanic, and African American women to guide the development of educational resources for women soldiers. An anonymous, questionnaire was completed by 455 U.S. Army women-Caucasian (CA: n = 141); Asian (AS: n = 67); Hispanic (HIS: n = 67); and African American (AA: n = 184) to compare menstrual patterns and concerns, dysmenorrhea, and oral contraceptive patterns. Total menstrual concerns were significantly lower among African Americans relative to Caucasians, Asians, or Hispanics; Asians and Hispanics reported the greatest concern. Overall, secondary amenorrhea was noted by 14.9% of women. Severe dysmenorrhea rates were significantly lower in African American (6.1%) compared to Caucasian (11.6%), Asian (20.9%) and Hispanic (19.7%) women. Asian women reported missing less work-only 9.3% with moderate to severe dysmenorrhea missed work compared to 25.1% of all other women. Only 9.2% of women with mild, compared to 25.8% with moderate to severe (OR = 3.44; p ≤ 0.0001) dysmenorrhea sought health care. Less than 50% of women took oral contraceptive, and less than half of those women took oral contraceptive continuously. African Americans seemed to experience menstruation as less bothersome than others, despite no difference in the proportion with menstrual irregularities, mean duration of menses, and/or mean time between cycles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21391160     DOI: 10.1080/03630242.2011.540742

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  1 in total

1.  Differences in pain subtypes between Hispanic and non-Hispanic white women with chronic vulvar pain.

Authors:  Ruby H N Nguyen; Robyn L Reese; Bernard L Harlow
Journal:  J Womens Health (Larchmt)       Date:  2015-01-20       Impact factor: 2.681

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.